Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 69 (2019): Issue 3 (September 2019)
Open Access
Inhibitory effect of taspine derivative TAD1822-7 on tumor cell growth and angiogenesis
via
suppression of EphrinB2 and related signaling pathways
Rui Liu
Rui Liu
,
Runze Yu
Runze Yu
,
Yuxin Cui
Yuxin Cui
,
Mengying Fan
Mengying Fan
,
Bo Wang
Bo Wang
and
Yanmin Zhang
Yanmin Zhang
| Jun 26, 2019
Acta Pharmaceutica
Volume 69 (2019): Issue 3 (September 2019)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jun 26, 2019
Page range:
423 - 431
Accepted:
Dec 03, 2018
DOI:
https://doi.org/10.2478/acph-2019-0021
Keywords
TAD1822-7
,
EphrinB2
,
Bel-7402 cells
,
proliferation
,
migration
,
anti-angiogenesis
© 2019 Rui Liu et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.